AKTS
Aktis Oncology, Inc.$18.78-1.31 (-6.52%)Prev Close$20.09·MCap$1.18B·P/E—·Vol262.5K·Yield—
▲
Buys (12M)
3
$39.25M
▼
Sells (12M)
0
$0.00
◆
Net Activity
Net Buyer
$39.25M
●
Active Insiders
3
last 12 mo
Over the past 12 months, insider activity at Aktis Oncology, Inc. (AKTS) has been exclusively buying, with 3 insider purchases totaling $39.25M and 0 insider sales totaling $0.00. The most recent insider transaction was by Foley Todd (Director), who purchased $4.19M worth of shares on Jan 12, 2026. Aktis Oncology, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $1.18B.
AKTS Insider Trading Activity
AKTS Insider Buying Activity
The following table shows recent insider purchases of Aktis Oncology, Inc. (AKTS) stock reported via SEC Form 4 filings.
AKTS Insider Selling Activity
The following table shows recent insider sales of Aktis Oncology, Inc. (AKTS) stock reported via SEC Form 4 filings.
No insider selling activity found for AKTS in the last 12 months.